About
Patrick Soon-Shiong is a South African-born American surgeon, biotech entrepreneur, and inventor of the cancer drug Abraxane. He founded NantWorks and ImmunityBio, serves as Executive Chairman of ImmunityBio and Chairman and CEO of NantHealth, and owns the Los Angeles Times. His work spans oncology, precision medicine, AI-enabled healthcare, media, philanthropy, and selective strategic investing.
Areas of interest
oncologyimmunotherapybiotechprecision medicineAI in healthcaremedical data infrastructuremediaclean energyfusionbattery technologyphilanthropy